Reply to: Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas

Christopher L Moertel¹, Angela C Hirbe¹, Laura J Klesse¹+3

• ¹Christopher L. Moertel, MD, Department of Pediatrics, University of Minnesota, Minneapolis, MN; Angela C. Hirbe, MD, PhD, Washington University School of Medicine in St Louis, St Louis, MO; Laura J. Klesse, MD, PhD, University of Texas Southwestern/Children's Health, Dallas, TX; P. Leia Nghiemphu, MD, University of California Los Angeles (UCLA), Los Angeles, CA; Dusica Babovic-Vuksanovic, MD, Mayo Clinic, Rochester, MN; and Timothy R. Gershon, MD, PhD, Department of Pediatrics, Emory University, Atlanta, GA.